Pharma Industry Insights & Resources

Celebrating Excellence: Pfizer CentreOne wins the CDMO Leadership Awards 2024

PC1 remains committed to accelerating the drug development journey and bringing medicine to patients more swiftly - because time is life.

Gene and cell therapy webinar

In this webinar, Pfizer scientists share their unique insights into how process, methods, and platform factors light the way for success, driving optimized yields, accelerated timelines to market, and more reliable process and manufacturing outcomes.

Gene and cell therapy

A CDMO with years of experience is crucial when producing life-changing gene and cell therapies, so choosing the right partner is key. Our experts are here to help you navigate the path to market, for your gene and cell therapy.

With a team comprising over 70 expert gene and cell therapy scientists, we leverage many years of working in this space to build and optimize our gene and cell therapy platform.

Download our brochure to see how we can bring your breakthrough to light

What to look for in a gene and cell therapy CDMO partner

Gene and cell therapies (GCTs) are offering life-changing new treatment options for genetic disorders. Our eBook examines the critical aspects of the development and manufacturing of GCTs and how we can help bring these therapeutics from clinical stages to commercialization.

Gene and cell therapy analytical and development methods: A path to success

Process development and analytical development are integral parts of gene therapy manufacturing. This whitepaper explores the analytical and development approaches needed to create a path to success in the clinic and beyond.

What Trends Will Shape the Pharma and Biotech Industries in 2023?

From adapting to budget constraints to weathering ongoing supply chain challenges, our industry experts discuss the forces that are driving current changes across the pharma and biotech sectors and share their insights into what we can expect in the market in 2023.

What Makes Us Altogether Different

For over 40 years, we've been listening, solving, and guiding our partners' drug projects to success. But what makes us an altogether different kind of CDMO to work with? Find out here.

Pearl River Site Spotlight

Streamline your journey with ADC excellence at Pearl River, NY.

Unraveling ADC complexities with bio-logic brilliance

Unravel the complexities of ADC development and production with a leading CDMO powered by Pfizer.

Sanford Site Spotlight

Unlock the bio-logic brilliance of your antibody therapeutics from Sanford, NC.

The future of innovative antibody therapeutics

Monoclonal antibodies (mAbs) represent an exciting field offering huge potential in the treatment of life-altering diseases – and the level of expectation over the next decade is sky-high. This application note outlines their rise, their future and the pathway to realize it.

Unravelling the complexities of ADC development and manufacturing: A path to success

Antibody-drug conjugates (ADCs) are revolutionizing the field of targeted cancer therapies, but their development and manufacturing processes pose significant complexities that must be addressed.